Diclofenac and misoprostol vs Tositumomab and Iodine I 131 Tositumomab

Interacting Drugs
Diclofenac and misoprostol
vs
Tositumomab and Iodine I 131 Tositumomab
Security Level
Minor, Monitor Therapy
Mechanism
Tositumomab and Iodine I 131 Tositumomab: Antiplatelet Agents may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse events may be increased.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Diclofenac and misoprostol vs Tositumomab and Iodine I 131 Tositumomab